EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanism of Metal Complexes in Alzheimer’s Disease

Yi Liu iD, Jiaying Ma iD, Qianling Zhang, Yi Wang, Qi Sun

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252211873 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yi Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory for Genome Stability & Disease Prevention, International Cancer Center, Department of Pharmacology, Shenzhen University Medi…. Hauptthemen laut MEDLINE: Alzheimer Disease, Coordination Complexes, tau Proteins, Amyloid beta-Peptides. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Shenzhen Key BasicResearch Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a kind of neurodegenerative diseases characterized by beta-amyloid deposition and neurofibrillary tangles and is also the main cause of dementia. According to statistics, the incidence of AD is constantly increasing, bringing a great burden to individuals and society. Nonetheless, there is no cure for AD, and the available drugs are very limited apart from cholinesterase inhibitors and N-Methyl-D-aspartic acid (NMDA) antagonists, which merely alleviate symptoms without delaying the progression of the disease. Therefore, there is an urgent need to develop a medicine that can delay the progression of AD or cure it. In recent years, increasing evidence suggests that metal complexes have the enormous potential to treat AD through inhibiting the aggregation and cytotoxicity of Aβ, interfering with the congregation and hyperphosphorylation of tau, regulating dysfunctional synaptic and unbalanced neurotransmitters, etc. In this review, we summarize the current metal complexes and their mechanisms of action for treating AD, including ruthenium, platinum, zinc, vanadium, copper, magnesium, and other complexes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCoordination Complexestau ProteinsAmyloid beta-PeptidesHumansAnimalsMetals

Stichwörter der Autor:innen

Alzheimer’s diseasemechanismmetal complexestherapeutics

Substanzen

Coordination Complexestau ProteinsAmyloid beta-PeptidesMetals

Autor:innen und Institutionen

  • Guangdong Key Laboratory for Genome Stability & Disease Prevention, International Cancer Center, Department of Pharmacology, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China.
  • College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518055, China.

ORCID-Profile: Yi Liu, Jiaying Ma

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Shenzhen Key BasicResearch Program
  • Shenzhen Medical Research Funds

Zitieren

APA

Liu, Y., Ma, J., Zhang, Q., Wang, Y., & Sun, Q. (2024). Mechanism of Metal Complexes in Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211873

Vancouver

Liu Y, Ma J, Zhang Q, Wang Y, Sun Q. Mechanism of Metal Complexes in Alzheimer’s Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211873

BibTeX
@article{Liu2024,
  author = {Liu, Yi and Ma, Jiaying and Zhang, Qianling and Wang, Yi and Sun, Qi},
  title = {Mechanism of Metal Complexes in Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252211873}
}
Kostenlos starten →